Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a cheap calcium shot make C-Sections safer?

NCT ID NCT07187544

Recruiting now Disease control Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving calcium chloride along with carbetocin (a longer-acting drug to tighten the uterus) improves uterine tone after planned C-sections. The goal is to reduce the risk of postpartum hemorrhage, a leading cause of maternal death. 120 low-risk women having scheduled C-sections will be randomly assigned to receive either the combo or carbetocin alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
carbetocin and calcium chloride
What this could lead to
If it works, this could offer a simple, low-cost way to lower the risk of severe bleeding after planned C-sections.
What could go wrong
This is a small, early-stage trial (120 people) and only includes low-risk planned C-sections, so results may not apply to emergency cases or higher-risk patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTPARTUM HEMORRHAGE (PRIMARY) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Postpartum Hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POSTPARTUM HEMORRHAGE (PRIMARY)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mount Sinai Hospital

    RECRUITING

    Toronto, Ontario, M5G1X5, Canada

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.